Albany Molecular Research Inc.

Research and Markets: Drug Discovery Technologies - A Global Update of Market Trends & Opportunities.
Business Wire; 11/18/2009; 682 words; ...13. Rest Of World Companies Profiled * * Abbott Laboratories (US) * Affymetrix Inc. (US) * Agilent Technologies Inc. (US) * Albany Molecular Research, Inc. (US) * Amersham Biosciences (US) * Applera Corporation (US) * ArQule Inc...

Drug Discovery Technologies - A Global Update of Market Trends & Opportunities.
M2 Presswire; 11/18/2009; 762 words; ...Europe 13. Rest Of World Companies Profiled - Abbott Laboratories (US) - Affymetrix Inc. (US) - Agilent Technologies Inc. (US) - Albany Molecular Research, Inc. (US) - Amersham Biosciences (US) - Applera Corporation (US) - ArQule Inc...

Third Compound from AMRI Bristol-Myers Squibb Collaboration Selected for Preclinical Development.
Biotech Week; 11/18/2009; 766 words; ...two companies (see also Albany Molecular Research, Inc.). Under the 2005 licensing...Pharmaceutical Company, Pre-Trials Research, Therapy, Treatment, Albany Molecular Research Inc. This article was prepared...

Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors.
PR Newswire; 11/17/2009; 1013 words; ...Presented at the Molecular Targets and Cancer...International Conference: Molecular Targets and Cancer...Oncology Hematology, Albany, NY; Scottsdale Clinical Research Institute/TGen...Therapeutics, Inc., Cambridge...Therapeutics, Inc. Mersana Therapeutics...

Third Compound from AMRI Bristol-Myers Squibb Collaboration Chosen for Preclinical Development
Wireless News; 11/10/2009; 365 words; ...milestone payment in the ongoing research collaboration between the two...inhibitors from AMRI's proprietary research program. To date, Bristol...of commercialized compounds. Albany Molecular Research, Inc. provides scientific services...